CD4 and neoplasm: Tumor-infiltrating CD4+ T cells have recently been correlated with favorable prognosis in OSCCs (52) however CD4+ T cells consist of several subpopulations (including Tregs) and CD4 expression as a prognostic biomarker in OSCCs and HNSCCs is controversial (40, 53–55).